These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 1374729

  • 1. [Prostatic specific antigen for detection and monitoring of prostatic cancer].
    Gofrit O, Pode D, Gez E, Pfau A, Roizman I, Lifshitz Y, Barak V.
    Harefuah; 1992 Mar 15; 122(6):345-8, 408. PubMed ID: 1374729
    [Abstract] [Full Text] [Related]

  • 2. [The role of prostate-specific antigen in the diagnosis and treatment of prostatic adenocarcinoma].
    Stamey TA.
    Urologe A; 1990 Mar 15; 29(2):52-64. PubMed ID: 1691883
    [Abstract] [Full Text] [Related]

  • 3. [Value of determining prostate specific antigen in follow-up of prostatic cancer].
    Sadeh AD, Mukamel E, Galili Y, Nussbaum B, Regev D, Servadio C.
    Harefuah; 1993 Aug 15; 125(3-4):69-74, 128. PubMed ID: 7693556
    [Abstract] [Full Text] [Related]

  • 4. [The clinical use of the prostate-specific antigen in patients with prostatic cancer].
    Matveev BP, Sokolov AV, Bukharkin BV, Ledian KM, Tilk AE, Makarova GV.
    Urol Nefrol (Mosk); 1991 Aug 15; (4):8-12. PubMed ID: 1719686
    [Abstract] [Full Text] [Related]

  • 5. Preoperative serum prostate specific antigen levels between 2 and 22 ng./ml. correlate poorly with post-radical prostatectomy cancer morphology: prostate specific antigen cure rates appear constant between 2 and 9 ng./ml.
    Stamey TA, Johnstone IM, McNeal JE, Lu AY, Yemoto CM.
    J Urol; 2002 Jan 15; 167(1):103-11. PubMed ID: 11743285
    [Abstract] [Full Text] [Related]

  • 6. Prostate-specific antigen (PSA). A tissue-specific and sensitive tumor marker.
    Mulders TM, Bruning PF, Bonfrer JM.
    Eur J Surg Oncol; 1990 Feb 15; 16(1):37-41. PubMed ID: 1689677
    [Abstract] [Full Text] [Related]

  • 7. Prostate specific antigen: clinical use in the diagnosis and management of prostate cancer.
    Kabalin JN.
    Geriatrics; 1992 Sep 15; 47(9):26-32. PubMed ID: 1380941
    [Abstract] [Full Text] [Related]

  • 8. Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate.
    Stamey TA, Yang N, Hay AR, McNeal JE, Freiha FS, Redwine E.
    N Engl J Med; 1987 Oct 08; 317(15):909-16. PubMed ID: 2442609
    [Abstract] [Full Text] [Related]

  • 9. Pre-operative percent free PSA predicts clinical outcomes in patients treated with radical prostatectomy with total PSA levels below 10 ng/ml.
    Shariat SF, Abdel-Aziz KF, Roehrborn CG, Lotan Y.
    Eur Urol; 2006 Feb 08; 49(2):293-302. PubMed ID: 16387412
    [Abstract] [Full Text] [Related]

  • 10. [PSA in the staging and monitoring of cancer of the prostate].
    Gil Sanz MJ, Sanz Velez JI, Liedana Torres JM, Roncales Badal AL, Allepuz Losa C, Rioja Sanz LA.
    Actas Urol Esp; 1991 Feb 08; 15(6):527-31. PubMed ID: 1724347
    [Abstract] [Full Text] [Related]

  • 11. [Prostate-specific antigen (PSA): diagnostic and prognostic implications in the evaluation of carcinoma of the prostate].
    Lo Cigno M, Montanari F, Bercovich E, Soli M, Emili E, Dal Pozzo C, Platè L, Bianchi D.
    Arch Ital Urol Nefrol Androl; 1989 Mar 08; 61(1):29-36. PubMed ID: 2469127
    [Abstract] [Full Text] [Related]

  • 12. [The value of prostate-specific antigen in therapy follow-up of prostatic carcinoma].
    Wirth MP, Pilarsky C.
    Urologe A; 1995 Jul 08; 34(4):297-302. PubMed ID: 7545844
    [Abstract] [Full Text] [Related]

  • 13. [Determination of prostatic specific antigen and prostatic acid phosphatase as tumor markers of cancer of the prostate].
    Morote Robles J, de Torres Mateos JA.
    Arch Esp Urol; 1989 Jul 08; 42 Suppl 2():124-30. PubMed ID: 2484148
    [Abstract] [Full Text] [Related]

  • 14. Undetectable prostate specific antigen at 6-12 months: a new marker for early success in hormonally treated patients after prostate brachytherapy.
    Miller N, Smolkin ME, Bissonette E, Theodorescu D.
    Cancer; 2005 Jun 15; 103(12):2499-506. PubMed ID: 15852361
    [Abstract] [Full Text] [Related]

  • 15. The role of P501S and PSA in the diagnosis of metastatic adenocarcinoma of the prostate.
    Sheridan T, Herawi M, Epstein JI, Illei PB.
    Am J Surg Pathol; 2007 Sep 15; 31(9):1351-5. PubMed ID: 17721190
    [Abstract] [Full Text] [Related]

  • 16. Tumor markers. Consensus Conference on Diagnosis and Prognostic Parameters in Localized Prostate Cancer. Stockholm, Sweden, May 12-13, 1993.
    Stamey TA, Ekman PE, Blankenstein MA, Cooper EH, Kontturi M, Lilja H, Oesterling JE, Stenman UH, Turkes A.
    Scand J Urol Nephrol Suppl; 1994 Sep 15; 162():73-87; discussion 115-27. PubMed ID: 7529430
    [Abstract] [Full Text] [Related]

  • 17. Prostate-specific antigen: a valuable clinical tool.
    Oesterling JE.
    Oncology (Williston Park); 1991 Apr 15; 5(4):107-22; discussion 122, 125-6, 128. PubMed ID: 1714288
    [Abstract] [Full Text] [Related]

  • 18. Correlation of cell proliferation marker (TPS), natural killer (NK) activity and tumor load serotest (PSA) in untreated and treated prostatic tumors.
    Tarle M, Kovacić K, Kastelan M.
    Anticancer Res; 1993 Apr 15; 13(1):215-8. PubMed ID: 7682800
    [Abstract] [Full Text] [Related]

  • 19. Preoperative PSA level significantly associated with interval to biochemical progression after radical retropubic prostatectomy.
    Gonzalez CM, Roehl KA, Antenor JV, Blunt LW, Han M, Catalona WJ.
    Urology; 2004 Oct 15; 64(4):723-8. PubMed ID: 15491709
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.